Clinical Trial Update: An Extension Study of AK002 in Patients With Eosinophilic Gastritis and/or Eosinophilic Duodenitis [Phase 2]

View source ↗

Summary

An extension Phase 2 trial of AK002 in eosinophilic gastritis and/or eosinophilic duodenitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Duodenitis
• Eosinophilic Gastritis
• Eosinophilic Gastroenteritis

Drugs mentioned

• AK002 (AK002)

Snippet

Sponsor: Allakos Inc. | Conditions: Eosinophilic Gastritis, Eosinophilic Gastroenteritis | Phase 2 | Status: COMPLETED | Results posted: 2024-02-28